Sunday soundbites

Reboxetine: bad drug or baddest drug?

On an utterly unrelated note, JAMA finds that fewer of its studies are funded by industry after more rigorous statistical oversight was put in place.

Alleles associated with disease don't decrease your lifespan.

Prediction of mild cognitive impairment using white matter connectivity.